Legal & General UCITS ETF - L&G Pharma Breakthrough UCITS ETF (DB:A2H9XR) - Stock Price, News & Analysis

A2H9XR Stock Overview

No business description

No updates

No updates

	A2H9XR	DE Capital Markets	DE Market
7D	2.1%	3.3%	2.0%
1Y	-18.3%	24.9%	2.0%

Return vs Industry: A2H9XR underperformed the German Capital Markets industry which returned 24.9% over the past year.

Return vs Market: A2H9XR underperformed the German Market which returned 2% over the past year.

Is A2H9XR's price volatile compared to industry and market?
A2H9XR volatility
A2H9XR Average Weekly Movement	2.0%
Capital Markets Industry Average Movement	4.6%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	10.2%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: A2H9XR has not had significant price volatility in the past 3 months.

Volatility Over Time: A2H9XR's weekly volatility (2%) has been stable over the past year.

Founded	Employees	CEO	Website
n/a	n/a	n/a	fundcentres.lgim.com/uk/private/fund-centre/ETF/Pharma-Breakthrough

How do Legal & General UCITS ETF - L&G Pharma Breakthrough UCITS ETF's earnings and revenue compare to its market cap?
A2H9XR fundamental statistics
Market cap	n/a
Earnings (TTM)	€0
Revenue (TTM)	n/a

P/E Ratio

P/S Ratio

Is A2H9XR overvalued?

Last Reported Earnings

n/a

Next Earnings Date

n/a

How did A2H9XR perform over the long term?